RxDoctor Payments Data

Septimio Gonzalez Savournin, APRN

Psychiatric/Mental Health · Naples, FLNPI 1053962589

Payments from drug & device makers

$1,375in general payments, 2019–2025

Across 67 payments — averaging $20.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$333
  • Alkermes, Inc.$189
  • Otsuka America Pharmaceutical, Inc.$160
  • Johnson & Johnson$153
  • Indivior Inc.$146
  • E.r. Squibb & Sons, L.L.C.$95
  • plus $300 from 6 others

What the payments were for

  • Food & beverage$1,27092%
  • Education$1048%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,375 in reported general payments places this provider in the 65th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida

Medicare billing

Part B allowed, 2024
$9,613
Medicare patients
31
Services billed
129

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate15$44,751
Aripiprazole16$4,039
Quetiapine Fumarate ErQuetiapine Fumarate29$1,137
Quetiapine Fumarate67$1,013
Clonazepam27$901
Bupropion XlBupropion Hcl38$559
Mirtazapine39$502
Fluoxetine Hcl26$330
Olanzapine14$306
Duloxetine Hcl21$304
Trazodone Hcl45$295
Lithium Carbonate ErLithium Carbonate16$269
Risperidone12$228
Lamotrigine36$223
Sertraline Hcl37$193

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$153$44,75115 claims
Almatica Pharma LLCSertraline Hcl$13$19337 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,096 psychiatric/mental health providers in Florida.

Other psychiatric/mental health in Naples

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →